FirasRMuwallaMD

PubMed

• Severe neutropenia following a prolonged course of vancomycin that progressed to agranulocytosis with drug reexposure.
  Duff, J. M., Moreb, J. S., Muwalla, F.> ;Ann Pharmacother. 2012 Jan
• Myeloma of the central nervous system: strong association with unfavorable chromosomal abnormalities and other high-risk disease features.
  Fassas, A. B., Ward, S., Muwalla, F., Van Hemert, R., Schluterman, K., Harik, S., Tricot, G.> ;Leuk Lymphoma. 2004 Feb
• Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant.
  Lee, C. K., Zangari, M., Barlogie, B., Fassas, A., van Rhee, F., Thertulien, R., Talamo, G., Muwalla, F., Anaissie, E., Hollmig, K., Tricot, G.> ;Bone Marrow Transplant. 2004 Apr
• Survival after relapse following tandem autotransplants in multiple myeloma patients: the University of Arkansas total therapy I experience.
  Fassas, A. B., Barlogie, B., Ward, S., Jagannath, S., Vesole, D., Mattox, S., Siegel, D., Muwalla, F., Zangari, M., Anaissie, E., Rhee, F. V., Thertulien, R., Lee, C. ...> ;Br J Haematol. 2003 Nov
• DTPACE: an effective, novel combination chemotherapy with thalidomide for previously treated patients with myeloma.
  Lee, C. K., Barlogie, B., Munshi, N., Zangari, M., Fassas, A., Jacobson, J., van Rhee, F., Cottler-Fox, M., Muwalla, F., Tricot, G.> ;J Clin Oncol. 2003 Jul 15
• Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning.
  Lee, C. K., Badros, A., Barlogie, B., Morris, C., Zangari, M., Fassas, A., van Rhee, F., Cottler-Fox, M., Jacobson, J., Thertulien, R., Muwalla, F., Mazher, S., Anaiss...> ;Exp Hematol. 2003 Jan
• Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy II.
  Shaughnessy, J., Tian, E., Sawyer, J., McCoy, J., Tricot, G., Jacobson, J., Anaissie, E., Zangari, M., Fassas, A., Muwalla, F., Morris, C., Barlogie, B.> ;Br J Haematol. 2003 Jan
• Transplantation as salvage therapy for high-risk patients with myeloma in relapse.
  Lee, C. K., Barlogie, B., Zangari, M., Fassas, A., Anaissie, E., Morris, C., Van Rhee, F., Cottler-Fox, M., Thertulien, R., Muwalla, F., Mazher, S., Badros, A., Tricot...> ;Bone Marrow Transplant. 2002 Dec
• Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma.
  Fassas, A. B., Spencer, T., Sawyer, J., Zangari, M., Lee, C. K., Anaissie, E., Muwalla, F., Morris, C., Barlogie, B., Tricot, G.> ;Br J Haematol. 2002 Sep
• Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations.
  Fassas, A. B., Muwalla, F., Berryman, T., Benramdane, R., Joseph, L., Anaissie, E., Sethi, R., Desikan, R., Siegel, D., Badros, A., Toor, A., Zangari, M., Morris, C., ...> ;Br J Haematol. 2002 Apr
• Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells.
  Zhan, F., Hardin, J., Kordsmeier, B., Bumm, K., Zheng, M., Tian, E., Sanderson, R., Yang, Y., Wilson, C., Zangari, M., Anaissie, E., Morris, C., Muwalla, F., van Rhee,...> ;Blood. 2002 Mar 1
• Results of autologous stem cell transplant in multiple myeloma patients with renal failure.
  Badros, A., Barlogie, B., Siegel, E., Roberts, J., Langmaid, C., Zangari, M., Desikan, R., Shaver, M. J., Fassas, A., McConnell, S., Muwalla, F., Barri, Y., Anaissie, ...> ;Br J Haematol. 2001 Sep
• Join now to see all